Showing results (1-10 of 227) with videos related to
Sort By:
Pageof 23
American Journal of Hematology|June 14, 2024
Still high risk? A review of translocation t(14;16) in multiple myelomaHira Mian, Martin Kaiser, Rafael FonsecaClinical Lymphoma, Myeloma & Leukemia|December 18, 2019
Adherence to Lenalidomide in Older Adults With Newly Diagnosed Multiple MyelomaHira Mian, Mark Fiala, Tanya M WildesLeukemia & Lymphoma|October 3, 2024
Optimizing multiple Myeloma clinical trials: research direction, addressing limitations, and strategies for improvementM S Ebraheem, M Gertz, Hira MianJCO Oncology Practice|June 17, 2026
Practical Management of Bispecific Antibodies in Multiple MyelomaCarlyn Rose Tan, Neha Korde, Hira MianBlood Cancer Journal|January 25, 2024
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic reviewKarun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, et al.Presse Medicale (Paris, France : 1983)|December 14, 2024
Treatment of elderly and frail myeloma patientsSteven Chun-Min Shih, Alissa Visram, Hira MianBlood Cancer Discovery|November 26, 2024
Total (Immuno)Therapy: Version 2.0Susan Bal, Luciano J CostaOncology and Therapy|October 22, 2025
Patient and Physician Perspectives on Multiple Myeloma Data Presented at ASCO and EHA 2025: A PodcastJenny Ahlstrom, Luciano J CostaAmerican Journal of Hematology|June 15, 2022
Bispecific T-cell engagers for treatment of multiple myelomaGayathri Ravi, Luciano J CostaClinical Advances in Hematology & Oncology : H&O|April 12, 2021
Best practices for the assessment of measurable residual disease (MRD) in multiple myelomaSusan Bal, Luciano J CostaPageof 23